Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Quest Diagnostics Incorporated (DGX) stocks in Canada

Learn how to easily invest in Quest Diagnostics Incorporated stocks.

Quest Diagnostics Incorporated is a diagnostics & research business based in the US. Quest Diagnostics Incorporated stocks (DGX.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $133.87 – an increase of 4.17% over the previous week. Quest Diagnostics Incorporated employs 50,000 staff and has a trailing 12-month revenue of around $10.7 billion.

How to buy stocks in Quest Diagnostics Incorporated

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DGX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Quest Diagnostics Incorporated stock price (NYSE:DGX)

Use our graph to track the performance of DGX stocks over time.

Quest Diagnostics Incorporated shares at a glance

Information last updated 2022-05-19.
Latest market close$141.03
52-week range$123.95 - $172.55
50-day moving average $137.94
200-day moving average $145.45
Wall St. target price$151.86
PE ratio 9.2351
Dividend yield $2.52 (1.88%)
Earnings per share (TTM) $15.07

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Quest Diagnostics Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Quest Diagnostics Incorporated price performance over time

Historical closes compared with the close of $141.03 from 2022-05-20

1 week (2022-05-12) N/A
1 month (2022-04-19) N/A
3 months (2022-02-23) 9.25%
6 months (2021-11-23) -6.63%
1 year (2021-05-21) 7.39%
2 years (2020-05-22) 24.99%
3 years (2019-05-23) 44.44%
5 years (2017-05-23) 32.41%

Is Quest Diagnostics Incorporated under- or over-valued?

Valuing Quest Diagnostics Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quest Diagnostics Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Quest Diagnostics Incorporated's P/E ratio

Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Quest Diagnostics Incorporated shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Quest Diagnostics Incorporated's PEG ratio

Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2373. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Quest Diagnostics Incorporated's EBITDA

Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.7 billion.

The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.

Quest Diagnostics Incorporated financials

Revenue TTM $10.7 billion
Operating margin TTM 21.44%
Gross profit TTM $4.2 billion
Return on assets TTM 10.46%
Return on equity TTM 29.38%
Profit margin 17.61%
Book value $54.50
Market capitalisation $16.3 billion

TTM: trailing 12 months

Quest Diagnostics Incorporated's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Quest Diagnostics Incorporated.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Quest Diagnostics Incorporated's total ESG risk score

Total ESG risk: 18.33

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Quest Diagnostics Incorporated's overall score of 18.33 (as at 01/01/2019) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Quest Diagnostics Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Quest Diagnostics Incorporated's environmental score

Environmental score: 0.86/100

Quest Diagnostics Incorporated's environmental score of 0.86 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Quest Diagnostics Incorporated's social score

Social score: 10.42/100

Quest Diagnostics Incorporated's social score of 10.42 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Quest Diagnostics Incorporated's governance score

Governance score: 5.77/100

Quest Diagnostics Incorporated's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Quest Diagnostics Incorporated's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Quest Diagnostics Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Quest Diagnostics Incorporated hasn't always managed to keep its nose clean.

Quest Diagnostics Incorporated share dividends

18%

Dividend payout ratio: 18.41% of net profits

Recently Quest Diagnostics Incorporated has paid out, on average, around 18.41% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.88% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Quest Diagnostics Incorporated shareholders could enjoy a 1.88% return on their shares, in the form of dividend payments. In Quest Diagnostics Incorporated's case, that would currently equate to about $2.52 per share.

While Quest Diagnostics Incorporated's payout ratio might seem low, this can signify that Quest Diagnostics Incorporated is investing more in its future growth.

Quest Diagnostics Incorporated's most recent dividend payout was on 20 April 2022. The latest dividend was paid out to all shareholders who bought their shares by 5 April 2022 (the "ex-dividend date").

Have Quest Diagnostics Incorporated's shares ever split?

Quest Diagnostics Incorporated's shares were split on a 2:1 basis on 21 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Quest Diagnostics Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Quest Diagnostics Incorporated shares which in turn could have impacted Quest Diagnostics Incorporated's share price.

Quest Diagnostics Incorporated share price volatility

Over the last 12 months, Quest Diagnostics Incorporated's shares have ranged in value from as little as $123.9531 up to $172.5506. A popular way to gauge a stock's volatility is its "beta".

DGX.US volatility(beta: 1.05)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Quest Diagnostics Incorporated's is 1.0473. This would suggest that Quest Diagnostics Incorporated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Quest Diagnostics Incorporated overview

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site